SOAR-CC-266961 New Task Order
Past New Requirement Updated
- Agency
-
National Institutes of Health
Department of Health and Human Services
- Solicitation expected
- Estimated value
- $250,000 to $700,000
- Set-aside
- Total Small Business
Forecast facts
- Anticipated award
- NAICS code
- 622110 General Medical and Surgical Hospitals
- Points of contact
-
- Marina Dorfeo-Connor dorfeoconnorm@cc.nih.gov
- Andrew Varley andrew.varley@nih.gov (301) 827-5851
Forecast details come from HHS's procurement forecast. Agencies' dates and values are estimates.
About this forecast
The National Institutes of Health forecasts a new task order, SOAR-CC-266961, for a BIOLOGIST position with an estimated solicitation release on July 1, 2026, and an estimated award on August 1, 2026. The total small business set-aside supports the clinical intramural research program of Daniel Chertow, MD, MPH, in the CCMD of the NIH Clinical Center and the Laboratory of Viral Zoonoses at the NIAID Biosafety Level 4 Integrated Research Facility at Fort Detrick, Maryland. The program evaluates the pathogenesis and treatment of high-consequence emerging viral pathogens, such as Ebola virus and Bundibugyo virus, in patient protocols, and the source states that a delay in filling the task order will compromise experiments addressing these pathogens.
The estimated award value range is $250,000 to $700,000 under NAICS 622110, General Medical and Surgical Hospitals. Work supports the NIAID Biosafety Level 4 Integrated Research Facility at Fort Detrick, Maryland. Points of contact are Marina Dorfeo-Connor (dorfeoconnorm@cc.nih.gov) and Andrew Varley, Contract Specialist (andrew.varley@nih.gov, +1 301-827-5851).
Forecast text
Clinical Research and Biosafety. This BIOLOGIST position will support the clinical intramural research program of Daniel Chertow, MD, MPH, in the CCMD of the NIH Clinical Center and the Laboratory of Viral Zoonoses at the NIAID Biosafety level 4 Integrated Research Facility at Fort Detrick, MD. Dr. Chertow's program evaluates the pathogenesis and treatment of high-consequence emerging viral pathogens, such as the Ebola virus and Bundibugyo virus in patient protocols. A delay in filling this task order will compromise the initiation and implementation of experiments aiming to prevent and treat these pathogens, which present a present and ongoing threat to US and global public health. If the services under this contract do not occur, then the initiation and pace of experiments seeking to mitigate the current Bundibugyo virus disease outbreak and future similar outbreaks will be compromised.
On GovTribe
Work this forecast
- Track it in your pipeline
- Find teaming partners
- Similar forecasts
- Ask GovTribe AI about this forecast